GlaxoSmithKline submits regulatory application for UMEC/VI

A.B. | ShareCast | 18 Dec, 2012 12:05 - Updated: 12:58 | | |


Pharmaceutical companies GlaxoSmithKline (GSK) and Theravance have submitted a regulatory application in the US for UMEC/VI medicine, used to treat chronic obstructive pulmonary disease (COPD).

UMEC/VI is an investigational once-daily LAMA/LABA combination medicine. It includes properties, umeclidinium bromide --- a long-acting muscarinic antagonist (LAMA)--- and vilanterol, a long-acting beta2 agonist which is administered using the Ellipta inhaler.

The application proposes the proprietary name Anora Ellipta and has been submitted to the US Food and Drug Administration for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema.

Applications for UMEC/VI are also planned in the European Union and in other countries next year.

FSTE 100 company GSK is a leading research-based pharmaceutical and healthcare company.

Theravance is a biopharmaceutical company which collaborates with a number of pharmaceutical organisations.


More news

22:18 US close: Stocks fall on PMI data, strict new tax laws and Middle East woes

US stocks slid as investors weighed worse-than-expected manufacturing data, tough new tax laws and tensions in the Middle East.

18:14 UK mortgage approvals slip in August, credit card borrowing rises

Housing market activity seems to be moderating just as demand for unsecured loans has begun to rise quite strongly, the latest data from the British Bankers Association (BBA) revealed.

17:37 Europe close: Stocks end lower on disappointing PMIs, Middle East tensions

European stocks were in the red as a report showed Eurozone manufacturing activity declined and as tensions flared in the Middle East.

17:35 Moss Bros director tops up stake after sales rise

Zoe Morgan, an independent non-executive director of men's clothing retailer Moss Bros, has together with her husband added 13,280 shares to their existing holding of 50,424.

17:34 Carnival pleases with Q3 results, raises guidance

Cruise operator Carnival pleased with its third quarter results, which showed strong customer demand and higher spending onboard its cruise ships.

17:33 Alibaba's founder becomes the richest person in China

Alibaba founder Jack Ma has become the richest man in China after the IT multinational’s boost to its initial public offering (IPO) to a world record of $25bn.

18:02 London close: Supermarkets lead stocks lower

Supermarkets led London's top flight lower on Tuesday after figures revealing three of the UK's biggest players losing sales and market share.

16:41 US airstrikes kill 70 IS fighters in Syria

The first airstrikes against Islamic State (IS) in Syria, launched by both the US and Arab allied states, have killed a reported 70 militants, according to activists on Tuesday.

16:35 US manufacturing PMI remains at high in September

The US manufacturing sector enjoyed the strongest expansion since the financial crisis during the third quarter, with a flash estimate from Markit's Purchasing Managers Index (PMI) showing unchanged reading of 57.9 in September.

16:27 FTSE 100 movers: Supermarket stocks slide after Kantar data

Tesco continued to slide a day after warning that it had "overestimated" its predicted first-half figures with more bad news coming in the form of the latest Kantar data, which showed another drop in the retailer's sales and market share.



Barclays set for record fine

Regulator set to impose huge fine for failing to ensure adequate protection for clients? funds.


The euro continues to slip against the dollar